RACA Market Cap History
Below is a table of the RACA market cap history going back to 7/8/2020:

Date RACA Market Cap

Also see: RACA Shares Outstanding History
and RACA YTD Return
RACA Historical Market Cap:
-11.69% CAGR
RACA Historical Market Cap: +-11.69% CAGR

Mouse over chart for data details
Therapeutics Acquisition is a newly organized blank check company incorporated in Delaware and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. Co.'s primary focus is on acquiring a business focusing on the healthcare industry, with an emphasis on the biotechnology sector. We show 4 historical shares outstanding datapoints in our RACA shares outstanding history coverage, used to compute RACA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RACA market cap history over the course of time is important for investors interested in comparing RACA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RACA versus a peer is one thing; comparing RACA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RACA can fluctuate over the course of history. With this page we aim to empower investors researching RACA by allowing them to research the RACA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree RACA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Therapeutics Acquisition (RACA) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

RACB Market Cap History
RACE Market Cap History
RAYS Market Cap History
RBAC Market Cap History
RBOT Market Cap History
RCHG Market Cap History
RCLF Market Cap History
RDBX Market Cap History
RDVY Market Cap History
RDW Market Cap History
More Miscellaneous companies »


RACA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.